Alexandre Belot

SARS-CoV-2 infected cells trigger an acute antiviral response mediated by Plasmacytoid dendritic cells in mild but not severe COVID-19 patients

M. Dreux, O. Allatif, D. Cluet, 2021, medRxiv.

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

J. Derisi, F. Rieux-Laucat, J. Fellay, 2023, Nature.

Phenotypic Variability in PRKCD: a Review of the Literature

A. Ramanan, S. Jolles, J. Bernatoniene, 2023, Journal of Clinical Immunology.

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

V. Tillmann, P. Soler-Palacín, T. Ozcelik, 2024, The Journal of experimental medicine.

Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

J. Gottenberg, L. Arnaud, J. Sibilia, 2021, Infectious Diseases and Therapy.

How to treat monogenic SLE?

Alexandre Belot, Jonathan Thuner, Jade Cognard, 2024, Best practice & research. Clinical rheumatology.

Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus.

F. Rieux-Laucat, N. Aladjidi, M. Malphettes, 2024, The Journal of experimental medicine.

Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members.

P. Meroni, A. Belot, R. Cimaz, 2009, Journal of autoimmunity.